These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37460331)

  • 1. ADAM10 as a biomarker for Alzheimer's disease: A systematic review.
    Oliveira Monteiro E Pereira de Almeida MP; Valle Pedroso R; Mantellatto Grigoli M; Vicente Silva T; Manzine PR; Cominetti MR
    Rev Neurol (Paris); 2024; 180(1-2):1-11. PubMed ID: 37460331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease.
    Pereira Vatanabe I; Peron R; Mantellatto Grigoli M; Pelucchi S; De Cesare G; Magalhães T; Manzine PR; Figueredo Balthazar ML; Di Luca M; Marcello E; Cominetti MR
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of ADAM10 are reduced in Alzheimer's disease CSF.
    Sogorb-Esteve A; García-Ayllón MS; Gobom J; Alom J; Zetterberg H; Blennow K; Sáez-Valero J
    J Neuroinflammation; 2018 Jul; 15(1):213. PubMed ID: 30045733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer's disease.
    Agüero P; Sainz MJ; García-Ayllón MS; Sáez-Valero J; Téllez R; Guerrero-López R; Pérez-Pérez J; Jiménez-Escrig A; Gómez-Tortosa E
    Alzheimers Res Ther; 2020 Oct; 12(1):139. PubMed ID: 33129344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.
    Colciaghi F; Borroni B; Pastorino L; Marcello E; Zimmermann M; Cattabeni F; Padovani A; Di Luca M
    Mol Med; 2002 Feb; 8(2):67-74. PubMed ID: 12080182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker.
    Manzine PR; Ettcheto M; Cano A; Busquets O; Marcello E; Pelucchi S; Di Luca M; Endres K; Olloquequi J; Camins A; Cominetti MR
    Biomed Pharmacother; 2019 May; 113():108661. PubMed ID: 30836275
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Agüero-Rabes P; Pérez-Pérez J; Cremades-Jimeno L; García-Ayllón MS; Gea-González A; Sainz MJ; Mahillo-Fernández I; Téllez R; Cárdaba B; Sáez-Valero J; Gómez-Tortosa E
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study.
    Oliveira Monteiro MPA; Salheb Oliveira DSM; Manzine PR; Crispim Nascimento CM; Dos Santos Orlandi AA; de Oliveira Gomes GA; Dos Santos Orlandi F; Zazzetta MS; Pott-Junior H; Cominetti MR
    Alzheimers Res Ther; 2021 Jan; 13(1):18. PubMed ID: 33419480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of ADAM10 in Alzheimer's Disease.
    Yuan XZ; Sun S; Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2017; 58(2):303-322. PubMed ID: 28409746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ADAM10 Levels and Their Association with Alzheimer's Disease Diagnosis in Older Adults with Fewer Years of Formal Education.
    Pelegrini LNC; da Silva VA; Grigoli MM; Vatanabe IP; Manzine PR; Cominetti MR
    Dement Geriatr Cogn Disord; 2024; 53(3):153-161. PubMed ID: 38583419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
    Shackleton B; Crawford F; Bachmeier C
    Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer's disease patients.
    Bram JMF; Talib LL; Joaquim HPG; Sarno TA; Gattaz WF; Forlenza OV
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):963-972. PubMed ID: 29845446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.
    Qin W; Ho L; Wang J; Peskind E; Pasinetti GM
    PLoS One; 2009; 4(1):e4183. PubMed ID: 19159013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDE2-RECK controls ADAM10 α-secretase-mediated cleavage of amyloid precursor protein.
    Nakamura M; Li Y; Choi BR; Matas-Rico E; Troncoso J; Takahashi C; Sockanathan S
    Sci Transl Med; 2021 Mar; 13(585):. PubMed ID: 33731436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10.
    Hitschler L; Lang T
    J Biol Chem; 2022 Jun; 298(6):101911. PubMed ID: 35398353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks.
    Reinhardt S; Stoye N; Luderer M; Kiefer F; Schmitt U; Lieb K; Endres K
    Sci Rep; 2018 Jan; 8(1):1329. PubMed ID: 29358714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease.
    Al-Atrache Z; Lopez DB; Hingley ST; Appelt DM
    BMC Neurosci; 2019 Feb; 20(1):6. PubMed ID: 30786875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
    Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
    Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner.
    Lopez Lloreda C; Chowdhury S; Ghura S; Alvarez-Periel E; Jordan-Sciutto K
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.